What You Should Know:
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services (AWS) to address the growing need for secure, scalable digital pathology solutions in the cloud.
Advancing Healthcare Through the Philips and AWS Partnership in Digital Pathology
The partnership between Philips and AWS combines Philips’ expertise in digitizing pathology with AWS’ leadership in scalable, secure cloud
Read More
Digital Pathology
Ibex and PathPresenter Partner to Expand AI-powered Digital Pathology
What You Should Know:
- Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, and PathPresenter, the leading global platform for pathology image sharing, announced a strategic partnership today.
- PathPresenter is a secure and scalable multi-tenant enterprise workflow platform that has been developed by pathologists with deep domain knowledge and experience.
- The strategic partnership aims to accelerate the adoption of AI-powered digital pathology solutions by
Read More
MEDITECH Launches Redesigned Expanse Pathology
What You Should Know:
- MEDITECH, a leader in healthcare information technology solutions, announces the release of its redesigned Expanse Pathology solution. This innovative tool, part of the company's comprehensive
- Expanse EHR, empowers pathologists with cutting-edge technology to tackle increasingly complex cases and collaborate seamlessly with other healthcare providers for improved patient care.
Expanse Pathology Key Features
The pathology industry is
Read More
FDA Clears Proscia’s Digital Pathology Solution for Cancer Diagnosis
What You Should Know:
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital pathology solution was cleared for the purpose of primary diagnosis.Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images
Read More
PathAI, Roche to Develop AI-Enabled Digital Pathology Algorithms for Companion Diagnostics
What You Should Know:
PathAI, a pioneering AI-powered precision pathology company, has just announced an exclusive collaboration with Roche Tissue Diagnostics (RTD) aimed at advancing AI-enabled interpretation for companion diagnostics.
Through this strategic partnership, PathAI will work exclusively with Roche Tissue Diagnostics to develop AI-enabled digital pathology algorithms specifically tailored for companion diagnostics.
Advance AI-enabled Interpretation for Companion
Read More
Mayo Clinic, Techcyte Partner to Create AI-Powered Pathology Platform
What You Should Know:
- Mayo Clinic Platformv and Techcyte have joined forces to revolutionize the field of pathology by creating a digital pathology platform. This platform aims to pioneer the next generation of pathology services through an open, AI-driven solution, enhancing treatment, efficiency, and accuracy globally.
- By enabling healthcare organizations to economically digitize their pathology practices, the platform integrates innovative technical and AI workflow
Read More
Dedalus, Ibex Launches AI-powered Digital Pathology Solution for Cancer Diagnosis
What You Should Know:
- Dedalus Group, an anatomic pathology information systems provider in Europe, and Ibex Medical Analytics, a market leader in AI-powered cancer diagnostics, have jointly launched an integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis.
A New Standard for Anatomic Pathology Lab Digitization
The new solution is now commercially available in major European markets and sets a new standard for anatomic pathology lab digitization by seamlessly
Read More
2023 Life Sciences Digital Pathology Adoption Survey Report
What You Should Know:
Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Over half of these organizations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics.The “2023
Read More
PathAI and ConcertAI Partner to Create Histopathology & Clinical RWD Solutions
What You Should Know:
PathAI, a provider of AI-powered pathology, and ConcertAI, an AI software-as-a-service (SaaS) technology and real-world evidence (RWE) solutions for life sciences and healthcare, today announced a strategic partnership to launch a first-in-class quantitative histopathology and curated clinical real-world data (RWD) solution.The solution combines PathAI's PathExplore™ tumor microenvironment panel with ConcertAI's Patient360™ and RWD360™
Read More
Spectrum Taps Proscia to Modernize its Pathology Operations
- Proscia®, a leading provider of digital and computational pathology solutions, today announced that Spectrum Healthcare Partners (SHCP), an independent, multispecialty, physician-owned healthcare practice, has selected Concentriq® Dx to modernize its pathology operations. In adopting Proscia’s software platform, SHCP will increase access to high-quality diagnostic services across Maine and New Hampshire, better informing treatment decisions for more patients.
- Digital pathology, which
Read More
